Cetuximab in combination with concurrent chemoradiotherapy (CRT) in locally advanced non-small cell lung carcinoma (NSCLC): A feasibility study

被引:0
|
作者
van den Heuvel, M. M.
Belderbos, J.
Dalesio, O.
van der Pol, M.
Uitterhoeve, L.
van de Vaart, P.
Verheij, M.
van Zandwijk, N.
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[2] Dr Bernard Verbeeten Inst, Tilburg, Netherlands
[3] Acad Med Ctr, Amsterdam, Netherlands
[4] Med Ctr Haaglanden, The Hague, Netherlands
[5] Univ Sydney, ADRI, Bernie Banton Ctr, Concord, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7540
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Cetuximab, in addition to concurrent chemo-radiotherapy (CRT) in locally advanced non-small cell lung carcinoma (NSCLC), a feasibility study
    Belderbos, Jose
    Verheij, Marcel
    Dalesio, Otilia
    van de Pol, Marjan
    Uitterhoeve, Lon
    van de Vaart, Paul
    van Zarldwijk, Nico
    Olmos, Valdes Renato
    Teertstra, Jelle
    van den Heuvel, Michel
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S847 - S848
  • [2] Induction chemotherapy followed by concurrent chemoradiotherapy (CRT) and surgery in locally advanced non-small cell lung carcinoma (NSCLC)
    Costa, MA
    Zukin, M
    Pinel, MI
    Roriz, W
    Zamboni, MM
    Cunha, ET
    Cordeiro, PB
    Torquato, E
    Goncalves, MCC
    Campos, L
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 95
  • [3] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [5] Phase I study of vorinostat with concurrent chemoradiotherapy (CRT) for locally advanced non-squamous non-small cell lung cancer (NSCLC).
    Mehra, Ranee
    Turaka, Aruna
    Meyer, Joshua E.
    Egleston, Brian L.
    Tanvetyanon, Tawee
    Pinder, Mary Colleen
    Dilling, Thomas J.
    Williams, Charles C.
    Gray, Jhanelle Elaine
    Shirai, Keisuke
    Alpaugh, R. Katherine
    Riordan, Debbie
    Somaiah, Neeta
    Shah, Prashant C.
    Scott, Walter Joseph
    Simon, George R.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Radical concurrent chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC)
    Stilwell, C. H.
    Shrimali, R. K.
    Sharma, R. N.
    Nicolson, M. C.
    Steven, E.
    Bissett, J. D.
    LUNG CANCER, 2013, 79 : S62 - S63
  • [7] Audit of chemoradiotherapy (CRT) in locally advanced non-small cell lung cancer
    Wong, S. -L.
    Morley, T.
    Meng, K.
    Mahmood, W.
    Forster, M.
    Mendes, R.
    LUNG CANCER, 2015, 87 : S53 - S53
  • [8] Metformin Use during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Wink, Krista
    Belderbos, Jose
    Dieleman, Edith
    Rossi, Maddalena
    Rasch, Coen
    Damhuis, Ronald
    Houben, Ruud
    Troost, Esther
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S278 - S279
  • [9] Phase II Study of Nimotuzumab in Combination With Concurrent Chemoradiation Therapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Nishimura, Y.
    Harada, H.
    Soejima, T.
    Tsujino, K.
    Hayakawa, K.
    Kozuka, T.
    Tanaka, M.
    Sasaki, T.
    Yamamoto, N.
    Nakagawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S68 - S68
  • [10] PHASE II STUDY OF NIMOTUZUMAB IN COMBINATION WITH CONCURRENT CHEMORADIOTHERAPY (CRT) IN PATIENTS WITH LOCALLY ADVANCED NONSMALL CELL LUNG CANCER (NSCLC).
    Hayakawa, Kazushige
    Nishimura, Yasumasa
    Harada, Hideyuki
    Soejima, Toshinori
    Tsujino, Kayoko
    Kozuka, Takuyo
    Tanaka, Masahiro
    Sasaki, Tomonari
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1146 - S1146